Ensysce Biosciences Inc Cash Flow Quality Index

Latest as of June 2026: -0.55x

Ensysce Biosciences Inc cash flow quality index. Ensysce Biosciences Inc (ENSC) has a Cash Flow Quality Index of -0.55x as of June 2026. Operating cash flow of $-1.96 Million is below net income of $3.56 Million, suggesting accrual-heavy earnings not yet converted to cash. See ENSC financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.55x
Operating CF / Net Income

Operating Cash Flow

$-1.96 Million
USD

Net Income

$3.56 Million
USD

Data as of

Jun 2026
Most recent filing

Cash Flow Quality Index of Ensysce Biosciences Inc (2019–2019)

Cash flow quality index of Ensysce Biosciences Inc from 2019 to 2019. Historical Cash Flow Quality Index for Ensysce Biosciences Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Ensysce Biosciences Inc (ENSC) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Ensysce Biosciences Inc Cash Flow Quality Index by Year (2019–2019)

Ensysce Biosciences Inc cash flow quality index by year from 2019 to 2019. Year-by-year earnings quality comparison for Ensysce Biosciences Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Ensysce Biosciences Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2019 30.04x $10.99 Million $365.95K —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.